Shares Of Tesla (TSLA) Rose By 6%, Pfizer (PFE), BioNTech (BNTX), AstraZeneca (AZN) Steady

0
548

Tesla, Inc. (TSLA), to $839.81, was up +5.83 percent. Though Elon Musk is defending Bitcoin and threatening Twitter short sellers, the price of Tesla is headed higher. He is taking advantage of Piper Sandler’s very bullish advice on Wall Street on Monday, which has just raised its price target to $1,200. A market capitalization of more than $1 trillion would result in such a target.


Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.

Sponsored


Pfizer Inc. (PFE) stayed stable at -0.28% to $35.8 and BioNTech SE (BNTX) also remained stable at -0.72% to $116.1. The US biotechnology company and the 75 million additional doses of its Covid-19 vaccine from its German affiliate are scheduled to be shipped to the European Union in the second quarter, said President Ursula von der Leyen of the European Commission.

The additional doses are part of a deal announced on 8 January, in which approximately half of the development of Pfizer/BioNTech vaccines this year will be agreed upon by the EU. Instead of the originally planned 1.3 billion, the US expects to manufacture up to 2 billion doses this year. Pfizer said that by the end of the year, 500 million doses would be available to the EU, with the possibility of purchasing an additional 100 million doses.

At -0.4 percent to $50.4, AstraZeneca PLC (AZN) was stable. Nine million more doses will be shipped to the European Union by AstraZeneca in the first quarter. For example, the British laboratory plans to include a total of 40 million doses of its covid vaccine, which was developed along with the University of Oxford, with 30 percent more doses.

The President of the European Commission, Ursula von der Leyen, has confirmed this. Deliveries will commence a week earlier than expected and the company will increase its manufacturing capacity for vaccines in Europe, the President of the EC said on Twitter.

LEAVE A REPLY

Please enter your comment!
Please enter your name here